May 23 2023
8:00 AM - 3:00 PM
West Orange, NJ
Life sciences companies are faced with an intricate web of legal updates. The Board of Directors needs to know what those updates are, and how those updates impact the company — now and in the future.
Please join Buchanan Life Sciences and the ACC of New Jersey as we consider best practices for keeping the Board informed and discuss the latest "cutting edge" topics impacting our industry. Both Buchanan lawyers and in-house practitioners will share their perspectives about key FDA, antitrust, litigation, employment and intellectual property law updates.
Life Sciences Company professionals who work in all aspects of the business (e.g. executive leadership, legal, finance, product pricing, product life cycle management, chief strategy officer, risk management, business development/licensing, market access, human resources, regulatory, medical, compliance) are invited to attend.
Register Here
Attendees are eligible for CLE credits, with 5 total credits pending, including 1 ethics.
Agenda for Buchanan Life Sciences Summit 2023
| 7:30 a.m. – 8:30 a.m. | Registration, Breakfast, Networking |
| 8:30 a.m. – 8:35 a.m. | Opening Remarks |
| 8:35 a.m. – 9:05 a.m. | What Stakeholders Need to Know: Top 10 Employment Issues and Key Takeaways |
| 9:05 a.m. – 10:05 a.m. | Ethical Insights for In-House Success |
| 10:05 a.m. – 10:15 a.m. | Break |
| 10:15 a.m. – 10:35 a.m. | Product Portfolio Value and Practical Updates for Your Board |
| 10:35 a.m. – 11:25 a.m. | Principles to Practice, Small Table Workshop: Real World Scenarios |
| 11:25 a.m. – 11:50 a.m. | Getting the Board On Board: When Changes in the Law Mandate Sweeping Shifts in Corporate Culture |
| 11:50 p.m. – 1:00 p.m. | Lunch Buffet, Networking |
| 1:00 p.m. – 2:00 p.m. | AI and Cybersecurity: Impact on Drug and Device
Development Intellectual Property Updates Impacting Asset Value Antitrust Law Updates Deciphered |
| 2:00 p.m. – 3:00 p.m. | Class Actions, Government Enforcement & Congressional Investigations: Best Practices for Board Updates & Mitigating Risk |